Apoptosis in the rheumatic diseases
- 1 November 1997
- journal article
- review article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 40 (11) , 1917-1927
- https://doi.org/10.1002/art.1780401102
Abstract
No abstract availableThis publication has 76 references indexed in Scilit:
- Defective CD3-Mediated Cell Death in Activated T Cells from Patients with Systemic Lupus Erythematosus: Role of Decreased Intracellular TNF-αClinical Immunology and Immunopathology, 1996
- Interleukin‐2 receptor common γ‐chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: Selective induction of anti‐apoptotic (bcl‐2, bcl‐xL) but not pro‐apoptotic (bax, bcl‐xS) gene expressionEuropean Journal of Immunology, 1996
- FAS Antigen Expression on Synovial Cells Was Down-Regulated by Interleukin 1βBiochemical and Biophysical Research Communications, 1996
- Fibromyalgia in womenArthritis & Rheumatism, 1995
- Apoptosis in the Pathogenesis and Treatment of DiseaseScience, 1995
- Expression and Function of Fas Antigen and bcl-2 in Human Systemic Lupus Erythematosus LymphocytesClinical Immunology and Immunopathology, 1994
- The apoptosis-1/Fas protein in human systemic lupus erythematosus.Journal of Clinical Investigation, 1994
- Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor αArthritis & Rheumatism, 1993
- Phagocyte recognition of cells undergoing apoptosisImmunology Today, 1993
- Death and the cellImmunology Today, 1986